SO
VTVT icon

STRS Ohio’s vTv Therapeutics VTVT Stock Holding History

STRS Ohio’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50
Closed -$12K – 1967
2016
Q2 		$11K Hold
50
– – ﹤0.01% 1883
2016
Q1 		$10K Hold
50
– – ﹤0.01% 1855
2015
Q4 		$13K Hold
50
– – ﹤0.01% 1872
2015
Q3 		$13K Buy
+50
New +$17.4K ﹤0.01% 1843

Other funds holding VTVT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $102M AUM 0.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

STRS Ohio's VTVT Position: Q3 2016 in Review

STRS Ohio sold out of vTv Therapeutics (VTVT) in Q3 2016, closing a stake of 50 shares — an estimated $12K sold.

STRS Ohio first reported a position in VTVT in Q3 2015 and held it in 4 quarters. The position peaked at $13K in Q4 2015. 36 funds tracked by Wall St. Rank hold VTVT as of Q3 2016.

  • STRS Ohio reported no remaining vTv Therapeutics position as of Q3 2016 after selling out during the quarter.
  • STRS Ohio sold 50 vTv Therapeutics shares in Q3 2016, an estimated $12K.
  • STRS Ohio first reported a position in vTv Therapeutics in Q3 2015 and held it in 4 quarters.
  • STRS Ohio's vTv Therapeutics position peaked at $13K in Q4 2015.
  • 36 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2016.

Based on STRS Ohio's 13F filing for Q3 2016, filed 27 Oct 2016.